Concepedia

John Mascarenhas

JM

Statistics

Publications

150

Citations

7.3K

H-Index

46

Active since

1996

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Mayo Clinic in Arizona

Cornell University

John Mascarenhas is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, hematology, and pathology.

ORCID

Top concepts

Publications per year

1996–2025

150

Publications

150

Complement-dependent Clearance of Apoptotic Cells by Human Macrophages

Dror Mevorach, John Mascarenhas, Debra Gershov et al. · The Journal of Experimental Medicine · 1998 · 690 citations · Full text

, , +16

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis

John Mascarenhas, Ronald Hoffman, Moshe Talpaz et al. · JAMA Oncology · 2018 · 358 citations · Full text

Modulation of NF-κB Activity and Apoptosis in Chronic Lymphocytic Leukemia B Cells

Richard R. Furman, Zahra Asgary, John Mascarenhas et al. · The Journal of Immunology · 2000 · 271 citations

Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis

John Mascarenhas, Ronald Hoffman · Clinical Cancer Research · 2012 · 231 citations

, , +16

The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome

Selçuk Sözer, Maria Isabel Fiel, Thomas D. Schiano et al. · Blood · 2009 · 186 citations · Full text

1–5 of 150